Global Drug Discovery Market 2022-2028

September 2022 | 86 pages | ID: G61700944A72EN
Gen Consulting Company

Abstracts

According to Gen Consulting Company, the global drug discovery market is set to achieve an incremental growth of USD 44 billion, acelerating at a CAGR of almost 8.7% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global drug discovery market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the drug discovery industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, drug type, disease application, end user, and region. The global market for drug discovery can be segmented by type: bioanalytical instruments, bioinformatics, cell-based assays and reagents, genomics, high-throughput screening, proteomics, others. The bioanalytical instruments segment was the largest contributor to the global drug discovery market in 2021. Drug discovery market is further segmented by drug type: biologics, small-molecule drugs. Based on disease application, the drug discovery market is segmented into: cancer, cardiovascular, immunological, neurological, others. The cancer segment held the largest revenue share in 2021. On the basis of end user, the drug discovery market also can be divided into: academia and research institutes, contract research organizations (CROs), pharmaceutical companies. Drug discovery market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By type:

• bioanalytical instruments
• bioinformatics
• cell-based assays and reagents
• genomics
• high-throughput screening
• proteomics
• others

By drug type:

• biologics
• small-molecule drugs

By disease application:

• cancer
• cardiovascular
• immunological
• neurological
• others

By end user:

• academia and research institutes
• contract research organizations (CROs)
• pharmaceutical companies

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Agilent Technologies Inc., AMETEK, Inc., Arrayit Corp., Becton, Dickinson and Company, Biomax Informatics AG, Bio-Rad Laboratories, Inc., Bruker Corp., Charles River Laboratories, Inc., Danaher Corp., General Electric Company (GE), Hitachi High-Technologies Corporation, Illumina, Inc., JEOL Ltd., LECO Corporation, Merck KGaA, Perkin Elmer Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global drug discovery market.
• To classify and forecast the global drug discovery market based on type, drug type, disease application, end user, region.
• To identify drivers and challenges for the global drug discovery market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global drug discovery market.
• To identify and analyze the profile of leading players operating in the global drug discovery market.

Why Choose This Report

• Gain a reliable outlook of the global drug discovery market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Bioanalytical instruments
Bioinformatics
Cell-based assays and reagents
Genomics
High-throughput screening
Proteomics
Others

PART 6. MARKET BREAKDOWN BY DRUG TYPE

Biologics
Small-molecule drugs

PART 7. MARKET BREAKDOWN BY DISEASE APPLICATION

Cancer
Cardiovascular
Immunological
Neurological
Others

PART 8. MARKET BREAKDOWN BY END USER

Academia and research institutes
Contract research organizations (CROs)
Pharmaceutical companies

PART 9. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 10. KEY COMPANIES

Agilent Technologies Inc.
AMETEK, Inc.
Arrayit Corp.
Becton, Dickinson and Company
Biomax Informatics AG
Bio-Rad Laboratories, Inc.
Bruker Corp.
Charles River Laboratories, Inc.
Danaher Corp.
General Electric Company (GE)
Hitachi High-Technologies Corporation
Illumina, Inc.
JEOL Ltd.
LECO Corporation
Merck KGaA
Perkin Elmer Inc.
Qiagen N.V.
Roche Holding AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER